Thomas W. Beetham's Net Worth
Estimate Recalculated Nov 11, 2024 01:19PM EST
Who is Thomas W. Beetham
Thomas W. Beetham has an estimated net worth of $10.1 Million. This is based on reported shares across multiple companies, which include Kiniksa Pharmaceuticals, Ltd., Magenta Therapeutics, Inc., and Viridian Therapeutics, Inc.\DE.
SEC CIK
Thomas W. Beetham's CIK is 0001741382
Past Insider Trading and Trends
2021 was Thomas W. Beetham's most active year for acquiring shares with 7 total transactions. Thomas W. Beetham's most active month to acquire stocks was the month of February. 2020 was Thomas W. Beetham's most active year for disposing of shares, totalling 8 transactions. Thomas W. Beetham's most active month to dispose stocks was the month of January. 2018 saw Thomas W. Beetham paying a total of $99,995.17 for 105,956 shares, this is the most they've acquired in one year. In 2020 Thomas W. Beetham cashed out on 107,093 shares for a total of $2,050,511.80, their largest year based on trade value.
Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
